Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Martina Pietralla"'
Autor:
Nina Buttmann-Schweiger, Karl Ulrich Petry, Martina Pietralla, Alexander Luyten, Axel Reinecke-Lüthge, Claudia Mauritz, Chris J.L.M. Meijer, K Luyten
Publikováno v:
International Journal of Cancer. 135:1408-1416
We evaluated compliance with human papillomavirus (HPV) testing and risk-adapted patient pathways and monitored changes in high-grade cervical disease during long-term follow-up. Women aged >30 years attending routine screening for cervical cancer we
Autor:
A. Reinecke-Lüthge, Alexander Luyten, K.-G. Theiler, B.-E. Braun, Karl Ulrich Petry, Martina Pietralla
Publikováno v:
Geburtshilfe und Frauenheilkunde. 68:268-273
OBJECTIVE: In February 2006 a pilot project was started in the city of Wolfsburg offering regular routine screening for cervical cancer to members of the Deutsche BKK, a large German health insurance company. The aims of the project are to investigat
Publikováno v:
Geburtshilfe und Frauenheilkunde. 71:304-306
Autor:
Alexander Luyten, K Luyten, S Strehlke, Karl Ulrich Petry, Claudia Mauritz, Martina Pietralla
Publikováno v:
Geburtshilfe und Frauenheilkunde. 74:981-982
Autor:
Alexander, Luyten, Nina, Buttmann-Schweiger, Katrin, Luyten, Claudia, Mauritz, Axel, Reinecke-Lüthge, Martina, Pietralla, Chris J L M, Meijer, Karl Ulrich, Petry
Publikováno v:
International journal of cancer. 135(6)
We evaluated compliance with human papillomavirus (HPV) testing and risk-adapted patient pathways and monitored changes in high-grade cervical disease during long-term follow-up. Women aged30 years attending routine screening for cervical cancer were
Autor:
Sarah Scherbring, Klaus Theiler, Alexander Luyten, Bernd Erich Braun, Martina Pietralla, K. Ulrich Petry, Axel Reinecke-Lüthge
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 46
Summary Background Currently, the German cervical cancer screening program encompasses an annual cytological Papanicolaou (Pap) smear. However, primary screening for cervical cancer using human papillomavirus (HPV) DNA testing detects cervical pre-ca